Response to Comment on Stiermaier et al. Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights From the International, Multicenter GEIST Registry. Diabetes Care 2018;41:1084-1088

被引:0
|
作者
Stiermaier, Thomas [1 ,2 ]
Santoro, Francesco [3 ]
El-Battrawy, Ibrahim [4 ,5 ]
Brunetti, Natale Daniele [3 ]
Akin, Ibrahim [4 ,5 ]
Eitel, Ingo [1 ,2 ]
机构
[1] Univ Heart Ctr Lubeck, Med Clin 2, Cardiol Angiol Intens Care Med, Lubeck, Germany
[2] German Ctr Cardiovasc Res DZHK, Lubeck, Germany
[3] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy
[4] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med 1, Fac Med, Mannheim, Germany
[5] German Ctr Cardiovasc Res, Mannheim, Germany
关键词
D O I
10.2337/dci18-0016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E122 / E122
页数:1
相关论文
共 16 条
  • [1] Comment on Stiermaier et al. Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights From the International, Multicenter GEIST Registry. Diabetes Care 2018;41:1084-1088
    Del Buono, Marco Giuseppe
    Carbone, Salvatore
    Abbate, Antonio
    [J]. DIABETES CARE, 2018, 41 (07) : E121 - E121
  • [2] Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights From the International, Multicenter GEIST Registry
    Stiermaier, Thomas
    Santoro, Francesco
    El-Battrawy, Ibrahim
    Moeller, Christian
    Graf, Tobias
    Novo, Giuseppina
    Santangelo, Andrea
    Mariano, Enrica
    Romeo, Francesco
    Caldarola, Pasquale
    Fanelli, Mario
    Thiele, Holger
    Brunetti, Natale Daniele
    Akin, Ibrahim
    Eitel, Ingo
    [J]. DIABETES CARE, 2018, 41 (05) : 1084 - 1088
  • [3] Response to Comment on Lacy et al. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care 2018;41:2339-2345
    Lacy, Mary E.
    Gilsanz, Paola
    Karter, Andrew J.
    Quesenberry, Charles P.
    Pletcher, Mark J.
    Whitmer, Rachel A.
    [J]. DIABETES CARE, 2019, 42 (04) : E69 - E69
  • [4] Response to Comment on Redondo et al. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care 2018;41:1017-1024
    Redondo, Maria Jose
    Libman, Ingrid
    Cheng, Peiyao
    Kollman, Craig
    Tosur, Mustafa
    Gal, Robin L.
    Bacha, Fida
    Klingensmith, Georgeanna J.
    Clements, Mark
    [J]. DIABETES CARE, 2018, 41 (07) : E125 - E126
  • [5] Response to Comment on Gordin et al. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 2018;41:815-822
    Gordin, Daniel
    King, George L.
    [J]. DIABETES CARE, 2018, 41 (07) : E128 - E128
  • [6] Comment on Redondo et al. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care 2018;41:1017-1024
    Nwosu, Benjamin U.
    [J]. DIABETES CARE, 2018, 41 (07) : E123 - E124
  • [7] Response to Comment on Andersen et al. Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care 2018;41:1955-1962
    Andersen, Signe T.
    Witte, Daniel R.
    Andersen, Henning
    Bjerg, Lasse
    Bruun, Niels Henrik
    Jorgensen, Marit E.
    Finnerup, Nanna B.
    Lauritzen, Torsten
    Jensen, Troels S.
    Tankisi, Hatice
    Charles, Morten
    [J]. DIABETES CARE, 2018, 41 (11) : E148 - E149
  • [8] Response to Comment on Feig et al. Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial. Diabetes Care 2018;41:2471-2479
    Feig, Denice S.
    Corcoy, Rosa
    Donovan, Lois E.
    Murphy, Kellie E.
    Barrett, Jon F. R.
    Sanchez, J. Johanna
    Ruedy, Katrina
    Kollman, Craig
    Tomlinson, George
    Murphy, Helen R.
    [J]. DIABETES CARE, 2019, 42 (06) : E98 - E99
  • [9] Response to Comment on Cheng et al. Trends and Disparities in Cardiovascular Mortality Among US Adults With and Without Self-Reported Diabetes, 1988-2015. Diabetes Care 2018;41:2306-2315
    Cheng, Yiling J.
    Imperatore, Giuseppina
    Albright, Ann L.
    Gregg, Edward W.
    [J]. DIABETES CARE, 2019, 42 (04) : E63 - E63
  • [10] Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431-2437
    Mathew, Anna V.
    Pennathur, Subramaniam
    [J]. DIABETES CARE, 2019, 42 (02) : E26 - E27